Cargando…
The synergistic antitumor effect of Huaier combined with 5-Florouracil in human cholangiocarcinoma cells
BACKGROUND: 5-Florouracil (5-FU) is a commonly used chemotherapeutic drug for cholangiocarcinoma, whereas it has unsatisfactory effect, and patients often have chemo-resistance to it. The combination of chemotherapeutic agents and traditional Chinese medicine has already exhibited a promising applic...
Autores principales: | Fu, Zhaoyu, Ma, Kexin, Dong, Bing, Zhao, Chongyu, Che, Chi, Dong, Chengyong, Zhang, Rixin, Wang, Haibo, Wang, Xiang, Liang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686517/ https://www.ncbi.nlm.nih.gov/pubmed/31391034 http://dx.doi.org/10.1186/s12906-019-2614-5 |
Ejemplares similares
-
Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
por: Ma, Kexin, et al.
Publicado: (2019) -
Anti-angiogenic and antitumor activities of Huaier aqueous extract
por: WANG, XIAOLONG, et al.
Publicado: (2012) -
Effect of lycopene as an adjuvant therapy with 5-florouracil in human colon cancer
por: Alhoshani, Norah M., et al.
Publicado: (2022) -
Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo
por: Chen, Tao, et al.
Publicado: (2021) -
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
por: Liu, Zhuo, et al.
Publicado: (2019)